The Foreign Corrupt Practices Act and the Medical Device Industry
November 12, 2007
In the Andrews Medical Device Litigation Reporter 2007, Foley Partner Sharie Brown comments how medical device companies must review their operations for corruption risk and develop policies that help prevent, detect and punish those who make or attempt to make corrupt payments to foreign officials on the company’s behalf.
Related Insights
July 17, 2025
Foley Viewpoints
Tricky Compliance Issues for Companies When an Executive Terminates Employment: Stock Options, Restricted Stock, and Other Equity Incentive Awards
Executive employment relationships are rarely permanent. When an executive or other senior-level employee terminates employment,…
July 17, 2025
Health Care Law Today
One Big Beautiful Bill: Slashed Budgets Will Disrupt the Medicaid Program
The new federal budget law, the One Big Beautiful Bill Act (the Act), enacted on July 4, 2025, makes dramatic changes to the Medicaid…
July 16, 2025
Foley Viewpoints
Changes to the College and University Endowment Tax
The One Big Beautiful Bill Act (OBBBA) modifies the excise tax on net investment income of private colleges and universities under…